Skip to content
Is the Pro-Life Movement on a Collision Course with the Coronavirus?
Andrew Egger /

Is the Pro-Life Movement on a Collision Course with the Coronavirus?

Weighing ethical concerns about the use of fetal-derived tissue to develop medicines against the public health risk of refusing vaccines.
Is the Pro-Life Movement on a Collision Course with the Coronavirus?

Amid the news explosion that followed President Trump’s COVID-19 diagnosis and brief convalescence earlier this month, there was a nugget you might have missed: The antibody treatment from biotech company Regeneron the president took—seemingly to great effect—had been developed in part by means of cells derived from fetal tissue.

Want to see more of The Dispatch in Google search?

Add Us as a Preferred Source

Andrew Egger is White House correspondent for The Bulwark. He previously covered politics for The Dispatch and The Weekly Standard.

More We Think You’d Like

Loading